TP53 aberrant Mantle Cell Lymphoma treated with first-line systemic therapy: A real-world analysis of outcomes in 120 patients treated in the United Kingdom
Rory McCulloch, Sunil Iyengar, Jessica Okosun, Mark Bishton et autres
0 citationsBlood
Nimish Shah
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
74Publications signalées
1452Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchViral-associated cancers and disordersCNS Lymphoma Diagnosis and TreatmentLung Cancer Treatments and Mutations
Publications récentes
Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study
Eliza A. Hawkes, Joanna Romejko‐Jarosińska, Wojciech Jurczak, Sunil Iyengar et autres
12 citationsBlood
Relapsed/Refractory Hodgkin lymphoma after first-line escalated beacopdac: Adverse outcomes are overcome by use of second-line targeted therapy - an international real-world analysis
Lisa Jeffers, Anna Santarsieri, Wendy Osborne, Florian Chevillon et autres
1 citationBlood
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
David Lewis, Lexy Sorrell, D. Wright, Annika Pasanen et autres
22 citationsThe Lancet
23 | RADIOTHERAPY IMPROVES PROGRESSION‐FREE SURVIVAL FOR STAGE IA NLPHL: A RETROSPECTIVE REPORT FROM THE GLOBAL NLPHL ONE WORKING GROUP (GLOW)
Jamie E. Flerlage, Dennis A. Eichenauer, Martina Fuchs, S. Hartmann et autres
1 citationHematological Oncology
The DIRECT study: A roadmap for ctDNA-based risk prediction, molecular profiling and MRD detection in Diffuse Large B Cell Lymphoma
Joanna A. Krupka, Ilias Moutsopoulos, Natasha H. Cutmore, Christopher S. Trethewey et autres
2 citationsmedRxiv
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper
Aisling Barrett, Nimish Shah, Andrew Chadwick, David Burns et autres
6 citationsBritish Journal of Haematology
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
E B Haynes, Kushani Ediriwickrema, Sarah Lawless, Kevin Joyce et autres
7 citationsBlood
Patient Experience with Venetoclax+Rituximab and BTK Inhibitors in Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL): A Qualitative Interview Study in the UK (ELECTRIC)
Dima El‐Sharkawi, Lisa Lowry, Jo Kelly, Hanna Kew et autres
0 citationsBlood
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Michael S. Binkley, Jamie E. Flerlage, Kerry J. Savage, Saad Akhtar et autres
22 citationsJournal of Clinical Oncology
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco et autres
26 citationsLeukemia
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Ming‐Qing Du, Chunye Zhang, Ellen Stelloo, Sharon Barrans et autres
1 citationResearch Square
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.